Whilst a handful of enterovirus vaccines are available, including for poliovirus (PV) and for EV-A71 (frequently responsible for serious outcomes of hand, foot and mouth disease) 1,2,3,4 , there are as yet no licenced anti-enterovirus drugs, despite evidence for efficacy in clinical trials and reports of extremely high potency for compounds targeting a pocket internal to capsid protein VP1 (termed here the P site) 5,6
These medications are prepared by licensed 503A pharmacies in accordance with the Federal Food, Drug, and Cosmetic Act
Manufactured by Zonex Pharma, GlutaOne Soap is a DRAP-approved, medicated soap bar developed for both face and full-body use
6.5.1 Technological innovations in exposure assessment 6.5.1.1 Advanced analytical technologies Single-cell omics approaches enable detection of EED-induced epigenetic changes in individual sperm cells, providing unprecedented precision in exposure assessment (145)
[PMC free article: PMC8729835] [PubMed: 34272327] 190